Business Development Clinical Development DNA Reagent 
Drug Discovery World
MAY 16, 2023
According to Foster, the industry needs to work together to address the problems from the earliest phases of pre-clinical development. Clinical endpoints are no longer the only things that matter. Lending to the time-to-clinic discrepancy, we also see increasing demands on manufacturing capacity for CGT reagents.”
Drug Discovery World
NOVEMBER 30, 2023
Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E. To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7
Expert insights. Personalized for you.
52 
Let's personalize your content